KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Deferred Taxes (2020 - 2025)

Pacira BioSciences has reported Deferred Taxes over the past 6 years, most recently at -$3.7 million for Q4 2025.

  • Quarterly results put Deferred Taxes at -$3.7 million for Q4 2025, down 206.73% from a year ago — trailing twelve months through Dec 2025 was $6.5 million (down 68.59% YoY), and the annual figure for FY2025 was $6.5 million, down 68.59%.
  • Deferred Taxes for Q4 2025 was -$3.7 million at Pacira BioSciences, down from $8.1 million in the prior quarter.
  • Over the last five years, Deferred Taxes for PCRX hit a ceiling of $12.5 million in Q2 2024 and a floor of -$10.8 million in Q4 2022.
  • Median Deferred Taxes over the past 5 years was $2.0 million (2021), compared with a mean of $2.3 million.
  • Biggest five-year swings in Deferred Taxes: crashed 25417.24% in 2023 and later skyrocketed 623.95% in 2025.
  • Pacira BioSciences' Deferred Taxes stood at -$2.1 million in 2021, then crashed by 420.9% to -$10.8 million in 2022, then surged by 160.89% to $6.6 million in 2023, then tumbled by 46.86% to $3.5 million in 2024, then tumbled by 206.73% to -$3.7 million in 2025.
  • The last three reported values for Deferred Taxes were -$3.7 million (Q4 2025), $8.1 million (Q3 2025), and $752000.0 (Q2 2025) per Business Quant data.